FDBusiness.com

Nestlé Extends Consumer Healthcare Portfolio in $2.3 Billion Deal

 Breaking News
  • AllinAll Ingredients Officially Opens New €5 Million Facility in Dublin An Taoiseach Leo Varadkar, TD (pictured above left), has officially opened AllinAll Ingredient’s new state-of-the-art manufacturing and Research and Development facility in Rosemount, Dublin. The company, which has been in the food industry for over 20 years, develops and manufactures ingredients, sauces and blends for the processed food market. Its R&D lead team have developed [...]...
  • Starbucks Extends Strategic Partnership With Arla Foods After seven years of a successful business partnership, Starbucks has a new strategic licensing agreement with the farmer-owned dairy co-operative Arla Foods. The two companies have signed a long-term 21-year strategic agreement, giving Arla Foods license to continue to manufacture, distribute and market Starbucks premium milk-based ready-to-drink (RTD) coffee beverages for the EMEA region (Europe, [...]...
  • Dual Quality of Food – European Commission Releases Common Testing Methodology The European Commission has just released a new common methodology for comparing the quality of food products across the EU. The Joint Research Centre (JRC), the European Commission’s Science and Knowledge service, has developed a common methodology to allow national consumer authorities to carry out tests comparing the composition and characteristics of food products sold [...]...
  • Müller Launches FRijj Ambient Range Müller has introduces FRijj with a longer lasting ambient recipe for the first time. The new FRijj ambient range is being produced at Müller’s Severnside site, which has benefited from substantial investment to create a new centre of excellence for milk drinks and fresh cream. Müller intends to use the increased capabilities at Severnside and across [...]...
  • Irish Gin Exports Up 433% in First Quarter of 2018 New CSO figures reveal that the value of Irish gin exports grew by a whopping 433 per cent in the first quarter of 2018, compared to the first quarter of 2017. In the first quarter of 2018, exports of Irish gin were valued at €935,000, compared to just €175,000 in the first quarter of 2017. [...]...

Nestlé Extends Consumer Healthcare Portfolio in $2.3 Billion Deal

Nestlé Extends Consumer Healthcare Portfolio in $2.3 Billion Deal
December 07
09:58 2017

Nestlé has agreed to acquire privately-held Atrium Innovations, a global leader in nutritional health products, from a group of investors led by Permira Funds for US$2.3 billion in cash. Atrium’s 2017 sales are expected to reach almost US$700 million.

The move supports Nestlé’s pursuit of growth opportunities in consumer healthcare to complement the company’s focus on its high-growth food and beverage categories. The transaction is expected to close in the first quarter of 2018 following the completion of customary approvals and closing conditions.

Upon closing, Atrium, with its corporate offices in Quebec, Canada, will become part of Nestlé Health Science. Its existing management team will continue to manage the business, led by Peter Luther, president and chief executive of Atrium Innovations.

Greg Behar, chief executive of Nestlé Health Science.

Greg Behar, chief executive of Nestlé Health Science, says: “We value Atrium’s history as a highly successful company and welcome its 1,400 employees to the Nestlé family. Their brands are a natural complement to our Consumer Care portfolio, which offers nutritional solutions in the areas of Healthy Aging, Healthy Growing, Gut Health and Obesity Care. Atrium’s portfolio will extend our product range with value-added solutions such as probiotics, plant-based protein nutrition, meal replacements and an extensive multivitamin line, enabling consumers to address their health and wellness goals.”

Greg Behar adds: “Atrium’s established brands are in attractive categories and have the potential for continued strong growth as part of Nestlé through category, channel and geographic expansion. It also represents additional offerings in the segment for non-GMO, organic and natural supplements, a fast-growing consumer trend, as well as a new sales channel.”

Atrium’s largest brand, Garden of Life®, is the leading brand in the natural supplement industry in the US. Garden of Life, headquartered in Palm Beach Gardens, Florida, manufactures certified organic, non-GMO supplements that are sold in more than 14,000 health food stores and online in the US, as well as select markets internationally.

Pure Encapsulations® is a full line of hypoallergenic, research-based dietary supplements, and is the #1 recommended brand in the U.S. Practitioner market. Pure Encapsulations, headquartered in Sudbury, Massachusetts, product line is free from common food allergens, GMOs, fillers, binders and artificial colors and are sold in the US via healthcare practitioners, online as well as in pharmacies in several markets in Europe.

The remainder of the Atrium portfolio includes strong specialty brands like Wobenzym®, Douglas Laboratories®, Genestra Brands™, Orthica®, AOV®, Minami® Klean Athlete®, Pharmax and Trophic™.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • June 25, 2018Packaged., The 7th Global Summit
  • September 5, 2018Int'l Food Products and Processing Technologies Exhibition (WorldFood Istanbul)
  • September 15, 2018iba
  • September 25, 2018PPMA Show 2018
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements